332 related articles for article (PubMed ID: 16380683)
1. Influence of personality disorder on the treatment of panic disorder--comparison study.
Prasko J; Houbová P; Novák T; Záleský R; Espa-Cervená K; Pasková B; Vyskocilová J
Neuro Endocrinol Lett; 2005 Dec; 26(6):667-74. PubMed ID: 16380683
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Personality Pathology on Treatment Outcome in Late-life Panic Disorder.
Gulpers B; Oude Voshaar R; Kampman M; Verhey F; VAN Alphen S; Hendriks GJ
J Psychiatr Pract; 2020 May; 26(3):164-174. PubMed ID: 32421288
[TBL] [Abstract][Full Text] [Related]
3. Facing the fear--clinical and neural effects of cognitive behavioural and pharmacotherapy in panic disorder with agoraphobia.
Liebscher C; Wittmann A; Gechter J; Schlagenhauf F; Lueken U; Plag J; Straube B; Pfleiderer B; Fehm L; Gerlach AL; Kircher T; Fydrich T; Deckert J; Wittchen HU; Heinz A; Arolt V; Ströhle A
Eur Neuropsychopharmacol; 2016 Mar; 26(3):431-44. PubMed ID: 26837851
[TBL] [Abstract][Full Text] [Related]
4. SECOND-STAGE TREATMENTS FOR RELATIVE NONRESPONDERS TO COGNITIVE BEHAVIORAL THERAPY (CBT) FOR PANIC DISORDER WITH OR WITHOUT AGORAPHOBIA-CONTINUED CBT VERSUS SSRI: A RANDOMIZED CONTROLLED TRIAL.
Payne LA; White KS; Gallagher MW; Woods SW; Shear MK; Gorman JM; Farchione TJ; Barlow DH
Depress Anxiety; 2016 May; 33(5):392-9. PubMed ID: 26663632
[TBL] [Abstract][Full Text] [Related]
5. Is there any influence of personality disorder on the short term intensive group cognitive behavioral therapy of social phobia?
Vyskocilova J; Prasko J; Novak T; Pohlova L
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Mar; 155(1):85-94. PubMed ID: 21475384
[TBL] [Abstract][Full Text] [Related]
6. Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder.
Bakker A; van Dyck R; Spinhoven P; van Balkom AJ
J Clin Psychiatry; 1999 Dec; 60(12):831-8. PubMed ID: 10665629
[TBL] [Abstract][Full Text] [Related]
7. Severity of panic disorder, adverse events in childhood, dissociation, self-stigma and comorbid personality disorders Part 1: Relationships between clinical, psychosocial and demographic factors in pharmacoresistant panic disorder patients.
Kolek A; Prasko J; Vanek J; Kantor K; Holubova M; Slepecky M; Nesnidal V; Latalova K; Ociskova M; Grambal A
Neuro Endocrinol Lett; 2019 Dec; 40(5):233-246. PubMed ID: 32112548
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of cognitive-behavioral therapy or selective serotonin reuptake inhibitor or both combined for panic disorder with or without agoraphobia: treatment results through 1-year follow-up.
van Apeldoorn FJ; Timmerman ME; Mersch PP; van Hout WJ; Visser S; van Dyck R; den Boer JA
J Clin Psychiatry; 2010 May; 71(5):574-86. PubMed ID: 20492852
[TBL] [Abstract][Full Text] [Related]
9. Investigating effective treatment factors in brief cognitive behavioral therapy for panic disorder.
Lim JA; Lee YI; Jang JH; Choi SH
Medicine (Baltimore); 2018 Sep; 97(38):e12422. PubMed ID: 30235717
[TBL] [Abstract][Full Text] [Related]
10. Severity of panic disorder, adverse events in childhood, dissociation, self-stigma and comorbid personality disorders Part 2: Therapeutic effectiveness of a combined cognitive behavioural therapy and pharmacotherapy in treatment-resistant inpatients.
Kolek A; Prasko J; Ociskova M; Holubova M; Vanek J; Grambal A; Slepecky M
Neuro Endocrinol Lett; 2019 Dec; 40(6):271-283. PubMed ID: 32200586
[TBL] [Abstract][Full Text] [Related]
11. An open study of the effectiveness of Internet treatment for panic disorder delivered in a psychiatric setting.
Bergström J; Andersson G; Karlsson A; Andréewitch S; Rück C; Carlbring P; Lindefors N
Nord J Psychiatry; 2009; 63(1):44-50. PubMed ID: 18985514
[TBL] [Abstract][Full Text] [Related]
12. Rate of improvement during and across three treatments for panic disorder with or without agoraphobia: cognitive behavioral therapy, selective serotonin reuptake inhibitor or both combined.
Van Apeldoorn FJ; Van Hout WJ; Timmerman ME; Mersch PP; den Boer JA
J Affect Disord; 2013 Sep; 150(2):313-9. PubMed ID: 23676529
[TBL] [Abstract][Full Text] [Related]
13. Clinical issues in the long-term treatment of panic disorder.
Rosenbaum JF; Pollack MH; Pollock RA
J Clin Psychiatry; 1996; 57 Suppl 10():44-8; discussion 49-50. PubMed ID: 8917131
[TBL] [Abstract][Full Text] [Related]
14. Depression does not affect the treatment outcome of CBT for panic and agoraphobia: results from a multicenter randomized trial.
Emmrich A; Beesdo-Baum K; Gloster AT; Knappe S; Höfler M; Arolt V; Deckert J; Gerlach AL; Hamm A; Kircher T; Lang T; Richter J; Ströhle A; Zwanzger P; Wittchen HU
Psychother Psychosom; 2012; 81(3):161-72. PubMed ID: 22399019
[TBL] [Abstract][Full Text] [Related]
15. Treatment of panic disorder with agoraphobia in an anxiety disorders clinic: factors influencing psychiatrists' treatment choices.
Starcevic V; Linden M; Uhlenhuth EH; Kolar D; Latas M
Psychiatry Res; 2004 Jan; 125(1):41-52. PubMed ID: 14967551
[TBL] [Abstract][Full Text] [Related]
16. [Effect of personality disorders on response to cognitive behavioral therapy of panic disorder with agoraphobia].
Marchand A; Wapler M
Can J Psychiatry; 1993 Apr; 38(3):163-6. PubMed ID: 8500066
[TBL] [Abstract][Full Text] [Related]
17. Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure.
Başoğlu M; Marks IM; Kiliç C; Swinson RP; Noshirvani H; Kuch K; O'Sullivan G
Br J Psychiatry; 1994 May; 164(5):647-52. PubMed ID: 7921715
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone.
Kampman M; Keijsers GP; Hoogduin CA; Hendriks GJ
J Clin Psychiatry; 2002 Sep; 63(9):772-7. PubMed ID: 12363116
[TBL] [Abstract][Full Text] [Related]
19. Does concurrent drug intake affect the long-term outcome of group cognitive behaviour therapy in panic disorder with or without agoraphobia?
Oei TP; Llamas M; Evans L
Behav Res Ther; 1997 Sep; 35(9):851-7. PubMed ID: 9299805
[TBL] [Abstract][Full Text] [Related]
20. A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder.
Roy-Byrne PP; Craske MG; Stein MB; Sullivan G; Bystritsky A; Katon W; Golinelli D; Sherbourne CD
Arch Gen Psychiatry; 2005 Mar; 62(3):290-8. PubMed ID: 15753242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
